Sumoylation of human argonaute 2 at lysine-402 regulates its stability

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Sahin, Umut ^a,b,c   Lapaquette, Pierre ^a,b,c   Andrieux, Alexandra ^a,b,c   Faure, Guilhem ^d   Dejean, Anne ^a,b,c  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c Cartes d'Identité des Tumeurs Program   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; LYSINE; PROTEIN UBC9; RANBP2 PROTEIN; SAE2 PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; CHAPERONE; EIF2C2 PROTEIN, HUMAN; NUCLEOPORIN; RAN-BINDING PROTEIN 2; SUMO PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN METABOLISM; PROTEIN STABILITY; RNA INTERFERENCE; SUMOYLATION; ANIMAL; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; TUMOR CELL LINE;

ANIMALS; ARGONAUTE PROTEINS; CELL LINE, TUMOR; GENE SILENCING; HELA CELLS; HUMANS; LYSINE; MICE; MOLECULAR CHAPERONES; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, SMALL INTERFERING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84904479804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102957     Document Type: Article

References (39)

1. van Kouwenhove M, Kedde M, Agami R (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656.
2. Hutvagner G, Simard MJ (2008) Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 9: 22-32.
3. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
4. Gu S, Kay MA (2010) How do miRNAs mediate translational repression? Silence 1: 11.
5. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441. (Pubitemid 39167657)
6. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, et al. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197. (Pubitemid 38950966)
7. Rand TA, Ginalski K, Grishin NV, Wang X (2004) Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc Natl Acad Sci U S A 101: 14385-14389. (Pubitemid 39346758)
8. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ (2010) A dicerindependent miRNA biogenesis pathway that requires Ago catalysis. Nature 465: 584-589.
9. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, et al. (2010) A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328: 1694-1698.
10. Diederichs S, Haber DA (2007) Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131: 1097-1108. (Pubitemid 350235019)
11. Ameyar-Zazoua M, Rachez C, Souidi M, Robin P, Fritsch L, et al. (2012) Argonaute proteins couple chromatin silencing to alternative splicing. Nat Struct Mol Biol 19: 998-1004.
12. Benhamed M, Herbig U, Ye T, Dejean A, Bischof O (2012) Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat Cell Biol 14: 266-275.
13. Wei W, Ba Z, Gao M, Wu Y, Ma Y, et al. (2012) A role for small RNAs in DNA double-strand break repair. Cell 149: 101-112.
14. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, et al. (2013) EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497: 383-387.
15. Rudel S, Wang Y, Lenobel R, Korner R, Hsiao HH, et al. (2010) Phosphorylation of human Argonaute proteins affects small RNA binding. Nucleic Acids Res 39: 2330-2343.
16. Zeng Y, Sankala H, Zhang X, Graves PR (2008) Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem J 413: 429-436.
17. Rybak A, Fuchs H, Hadian K, Smirnova L, Wulczyn EA, et al. (2009) The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2. Nat Cell Biol 11: 1411-1420.
18. Qi HH, Ongusaha PP, Myllyharju J, Cheng D, Pakkanen O, et al. (2008) Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455: 421-424.
19. Cubenas-Potts C, Matunis MJ (2013) SUMO: a multifaceted modifier of chromatin structure and function. Dev Cell 24: 1-12.
20. Ouyang J, Valin A, Gill G (2009) Regulation of transcription factor activity by SUMO modification. Methods Mol Biol 497: 141-152.
21. Ulrich HD (2012) Ubiquitin and SUMO in DNA repair at a glance. J Cell Sci 125: 249-254.
22. Neyret-Kahn H, Benhamed M, Ye T, Le Gras S, Cossec JC, et al. (2013) Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation. Genome Res 23: 1563-1579.
23. Praefcke GJ, Hofmann K, Dohmen RJ (2012) SUMO playing tag with ubiquitin. Trends Biochem Sci 37: 23-31.
24. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, et al. (2009) PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. Embo J 28: 3534-3548.
25. Kirsh O, Seeler JS, Pichler A, Gast A, Muller S, et al. (2002) The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. Embo J 21: 2682-2691. (Pubitemid 34619384)
26. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120. (Pubitemid 34137016)
27. Gareau JR, Lima CD (2010) The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 11: 861-871.
28. Desterro JM, Rodriguez MS, Hay RT (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239. (Pubitemid 128373648)
29. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, et al. (2004) SUMO modification of Huntingtin and Huntington's disease pathology. Science 304: 100-104. (Pubitemid 38451465)
30. Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, et al. (2011) Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Gastroenterology 140: 286-296.
31. Heo I, Kim VN (2009) Regulating the regulators: posttranslational modifications of RNA silencing factors. Cell 139: 28-31.
32. Kim YK, Heo I, Kim VN (2010) Modifications of small RNAs and their associated proteins. Cell 143: 703-709.
33. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, et al. (2008) Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 10: 547-555. (Pubitemid 351627374)
34. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, et al. (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10: 538-546. (Pubitemid 351627373)
35. Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, et al. (2013) Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. Mol Cell Biol 33: 2163-2177.
36. Maison C, Bailly D, Roche D, Montes de Oca R, Probst AV, et al. (2011) SUMOylation promotes de novo targeting of HP1alpha to pericentric heterochromatin. Nat Genet 43: 220-227.
37. Mo YY, Moschos SJ (2005) Targeting Ubc9 for cancer therapy. Expert Opin Ther Targets 9: 1203-1216.
38. Voller D, Reinders J, Meister G, Bosserhoff AK (2013) Strong reduction of AGO2 expression in melanoma and cellular consequences. Br J Cancer.
39. Deribe YL, Pawson T, Dikic I (2010) Post-translational modifications in signal integration. Nat Struct Mol Biol 17: 666-672.